在早期齐多夫丁治疗期间,HIV-1 RNA血清载荷和耐药病毒基因型
C Loveday1, S Kaye, M Tenant-Flowers
1Division of Virology, University College London Medical School, London.
Lancet (London, England)
|April 1, 1995
概括
最初的齐多夫丁 (ZDV) 治疗迅速抑制了HIV-1RNA和p24抗原水平在患有严重HIV疾病的患者. 然而,药物耐药性突变迅速出现,限制了ZDV.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 齐多丁 (ZDV) 是一种核酸逆转录酶抑制剂,用于治疗HIV-1感染.
- 了解早期的病毒学反应和对ZDV的耐药性发展对于优化治疗策略至关重要.
- 严重的艾滋病毒疾病对抗逆转录病毒疗法的有效性提出了独特的挑战.
研究的目的:
- 评估艾滋病毒-1在患有严重艾滋病毒疾病的患者中对初始ZDV治疗的早期反应.
- 在ZDV治疗期间量化血清HIV-1RNA和p24抗原水平.
- 确定HIV逆转录酶 (RT) 基因中ZDV耐药性突变的出现和演变.
主要方法:
- 血清HIV-1RNA和p24抗原的培养独立量化.
- 对与ZDV耐药性相关的HIV逆转录酶 (RT) 基因突变的分析.
- 在11名患者中,对病毒标记物和药物耐药性的纵向监测.
主要成果:
- 血清HIV-1RNA和p24抗原的快速下降在ZDV启动后的1-7天内被观察到.
- 血清HIV-1RNA水平在几周内恢复到治疗前的水平.
- 几个月内,HIV RT基因中出现了耐药性突变,其中一名患者早在25天就出现了突变.
- 观察到的突变并不能完全解释早期的病毒载荷反弹,治疗后出现的抗药性模式.
结论:
- 最初的ZDV治疗导致严重的艾滋病毒疾病的病毒载量迅速但暂时减少.
- 迅速出现的ZDV耐药性对这种药物的有限的长期疗效作出了重大贡献.
- 病毒载量和抗药性发展之间的动态相互作用凸显了组合治疗和仔细监测的必要性,特别是在怀孕等短期干预中.
相关概念视频
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...


